Challenging the Current Paradigm for ADA Testing
21-22 September 2023, NH Málaga, Spain
Program
The ‘W4’ of Metabolite profiling and quantification strategies in drug R&D:
When, What, Why and Who?
The program can also be downloaded as a pdf.
24 September 2015 | ||
17:00 – | 20:00 | Registration desk opens |
25 September 2015 | ||
07.30 – | 09.00 | Registration desk opens |
09.00 – | 09.05 | Welcome and aim of the meeting |
09.05 – | 09.30 | Scientific and regulatory environment in metabolite profiling and quantification today |
(presenter: from EBF), including FB from EBF Survey | ||
09.30 – | 09.55 | Preceding scientific drivers and tools to influence metabolic profiling in the regulatory space |
(presenter: Claude Delatour, UCB BioPharma) | ||
09.55 – | 10.20 | Current practices and future vision on metabolite profiling and quantification in Boehringer-Ingelheim |
(presenter: Stefan Blech, Boehringer-Ingelheim) | ||
10.20 – | 10.50 | Coffee break |
10.50 – | 11.15 | Current practices and future vision on metabolite profiling and quantification in GlaxoSmithKline |
(presenter: Graeme Young, GlaxoSmithKline) | ||
11.15 – | 11.40 | Current practices and future vision on metabolite profiling and quantification in Janssen R&D |
(presenter: Geert Mannens, Janssen R&D) | ||
11.40 – | 12.10 | How to manage metabolite profiling requests from a CRO perspective? |
(presenter: Chris Lowrie, Charles River) | ||
12.10 – | 13.00 | Lunch |
13.00 – | 15.00 | Workshop: towards best practice |
13:00 – | 13.30 | – A ‘best practice’ starting proposal (EBF presenter) |
13:30 – | 15:00 | – workshop discussion including multi stakeholder input |
(Moderators: presenters from morning sessions) | ||
15.00 – | 15.30 | Coffee break |
15.30 – | 16.30 | Summary, conclusion and next steps |
16:30 | Adjourn |
__________________________________________________________________________________
Meeting Organisation
Stefan Blech, Boehringer Ingelheim – John Smeraglia, UCB – Steve White, GlaxoSmithKline – Stephen Williams, CRL – Stuart McDougall, Covance – Philip Timmerman, Janssen R&D
The conference is organised as a non-sponsored non-profit event by European Bioanalysis Forum VZW